arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

VIEMED HEALTHCARE, INC.

VMD
$9.01 ▼ -1.09 (-10.79%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
35 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
65
Health
Good
Bullish
auto_awesome

Analytical Summary

VIEMED HEALTHCARE, INC. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $344.6M
Dividend Yield —
Revenue Growth 23.9% ↘
Op. Margin 5.7% →
ROIC 2.1% ↗
FCF / Share $0.19 ↗
Trailing P/E 128.7x
Price / Book 2.4x
FCF Yield 2.2%
Debt / Equity 0.04
info Valuation on last close. End-of-day price, Nov 5, 2026.

35-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$78.10M
↑ +23.9% —
Net Income Profit after all expenses
$2.76M
↓ -12.4% —
Operating Margin Operating profit as % of sales
5.7%
— +0.3% 53th
FCF / Share Free cash flow per share
$0.19
↑ +450.2% —
Long-Term Debt Long-term obligations
$6.37M
↓ -23.5% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
49
Returns ↑
69
Financial Health →
87
Cash Quality ↑
54

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 9 years · 35 quarters